Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Amazon
AMZN
|
+$842M |
| 2 |
NVIDIA
NVDA
|
+$559M |
| 3 |
Microsoft
MSFT
|
+$420M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Moderna
MRNA
|
+$365M |
Top Sells
| 1 |
Baidu
BIDU
|
+$628M |
| 2 |
Tesla
TSLA
|
+$424M |
| 3 |
Palo Alto Networks
PANW
|
+$417M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$415M |
| 5 |
AT&T
T
|
+$389M |
Sector Composition
| 1 | Healthcare | 19.94% |
| 2 | Technology | 19.65% |
| 3 | Consumer Staples | 10.63% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Communication Services | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Entergy
ETR
$39.5B
| $12.4M | 0.02% |
248,200
-362,000
| -59% | -$18M |
|
1027
Lufax Holding
LU
$2.54B
| $12.4M | 0.02% |
+273,700
| New | +$12.4M |
|
1028
Cambium Networks
CMBM
$19.8M
| $12.4M | 0.02% |
255,700
+15,000
| +6% | +$725K |
|
1029
Progyny
PGNY
$1.95B
| $12.4M | 0.02% |
209,400
+46,000
| +28% | +$2.71M |
|
1030
Vanguard Short-Term Bond ETF
BSV
$38.5B
| $12.3M | 0.02% |
+150,009
| New | +$12.3M |
|
1031
Cato Corp
CATO
$89.6M
| $12.3M | 0.02% |
729,102
-87,250
| -11% | -$1.47M |
|
1032
Boise Cascade
BCC
$3.21B
| $12.3M | 0.02% |
210,600
+68,800
| +49% | +$4.01M |
|
1033
Gilat Satellite Networks
GILT
$605M
| $12.3M | 0.02% |
1,205,008
-235,401
| -16% | -$2.4M |
|
1034
Xenon Pharmaceuticals
XENE
$2.86B
| $12.3M | 0.02% |
657,977
-35,000
| -5% | -$652K |
|
1035
ASGN Inc
ASGN
$2.23B
| $12.3M | 0.02% |
126,394
+106,900
| +548% | +$10.4M |
|
1036
Prothena Corp
PRTA
$447M
| $12.3M | 0.02% |
238,300
-50,700
| -18% | -$2.61M |
|
1037
IES Holdings
IESC
$7.57B
| $12.2M | 0.02% |
237,732
-26,100
| -10% | -$1.34M |
|
1038
American Homes 4 Rent
AMH
$12.7B
| $12.2M | 0.02% |
313,732
-47,297
| -13% | -$1.84M |
|
1039
Full House Resorts
FLL
$120M
| $12.2M | 0.02% |
1,225,290
+24,300
| +2% | +$242K |
|
1040
Celldex Therapeutics
CLDX
$1.66B
| $12.2M | 0.02% |
364,027
-177,400
| -33% | -$5.93M |
|
1041
CVR Energy
CVI
$3.21B
| $12.2M | 0.02% |
677,284
-501,300
| -43% | -$9M |
|
1042
Citi Trends
CTRN
$286M
| $12.2M | 0.02% |
139,758
+675
| +0.5% | +$58.7K |
|
1043
TrueCar
TRUE
$172M
| $12.2M | 0.02% |
2,150,701
-152,800
| -7% | -$863K |
|
|
PTNR
1044
DELISTED
Partner Communications
PTNR
| $12.1M | 0.02% |
2,642,650
-25,000
| -0.9% | -$115K |
|
|
KIN
1045
DELISTED
Kindred Biosciences, Inc.
KIN
| $12.1M | 0.02% |
1,321,859
-95,000
| -7% | -$871K |
|
1046
AstraZeneca
AZN
$251B
| $12.1M | 0.02% |
201,700
+182,800
| +967% | +$10.9M |
|
1047
Watts Water Technologies
WTS
$9.29B
| $12.1M | 0.02% |
82,800
-18,000
| -18% | -$2.63M |
|
1048
Oil-Dri
ODC
$960M
| $12.1M | 0.02% |
706,692
-40,000
| -5% | -$684K |
|
1049
American Outdoor Brands
AOUT
$111M
| $12.1M | 0.02% |
343,268
+10,600
| +3% | +$372K |
|
|
OIIM
1050
DELISTED
02Micro International Limited
OIIM
| $12.1M | 0.02% |
1,672,862
-128,994
| -7% | -$930K |
|